Outcomes of Laparoscopic and Robotic Partial Nephrectomy for Large (>4 Cm) Kidney Tumors: Systematic Review and

Nicola Pavan1, Ithaar H Derweesh2, Carme Maria Mir3

  • 1Urology Clinic, Department of Medical, Surgical and Health Science, University of Trieste, Trieste, Italy.

Abstract

Insights

Minimally invasive partial nephrectomy (MIPN) is effective for large renal masses (>4 cm), offering good functional outcomes without increasing positive surgical margins. However, surgeons should anticipate a higher rate of complications with larger tumors.

Area of Science:

  • Urology
  • Surgical Oncology
  • Nephrology

Background:

  • Renal masses larger than 4 cm present unique surgical challenges.
  • Minimally invasive partial nephrectomy (MIPN) has become a standard treatment for renal tumors.
  • Assessing the safety and efficacy of MIPN for larger renal masses is crucial.

Purpose of the Study:

  • To evaluate the outcomes of minimally invasive (laparoscopic and robotic) partial nephrectomy (MIPN) for large renal masses (>4 cm).
  • To compare MIPN outcomes for tumors >4 cm versus tumors <4 cm.

Main Methods:

  • A systematic literature review was conducted using PRISMA criteria.
  • Studies comparing MIPN for tumors >4 cm with MIPN for tumors <4 cm were identified.
  • Surgical, functional, and oncological parameters were extracted and analyzed.

Main Results:

  • Analysis of 13 studies (4441 tumors <4 cm, 1024 tumors >4 cm) revealed shorter warm ischemia time and fewer perioperative complications for smaller tumors.
  • No significant differences were observed in postoperative kidney function (eGFR, CKD onset) or positive surgical margins between the groups.
  • Sensitivity analyses were performed for laparoscopic and robotic partial nephrectomy separately.

Conclusions:

  • MIPN is a viable option for renal masses larger than 4 cm, providing good functional outcomes and no increased risk of positive surgical margins.
  • An increased rate of perioperative complications should be considered when performing MIPN for larger renal masses.